Personal tools

MCL coexpression mm9:1894: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0001017!4.65e-34!73;UBERON:0001016!5.27e-34!75;UBERON:0004121!2.22e-28!95;UBERON:0000924!2.22e-28!95;UBERON:0006601!2.22e-28!95;UBERON:0002346!4.10e-23!64;UBERON:0003075!4.10e-23!64;UBERON:0007284!4.10e-23!64;UBERON:0000073!3.85e-21!54;UBERON:0001049!4.77e-20!52;UBERON:0005068!4.77e-20!52;UBERON:0006241!4.77e-20!52;UBERON:0007135!4.77e-20!52;UBERON:0010371!1.00e-19!73;UBERON:0002020!3.33e-19!34;UBERON:0010314!2.53e-17!92;UBERON:0000955!2.01e-16!47;UBERON:0006238!2.01e-16!47;UBERON:0003056!3.91e-16!49;UBERON:0002616!9.14e-16!46;UBERON:0003080!2.36e-15!40;UBERON:0003528!3.91e-15!29;UBERON:0002791!3.91e-15!29;UBERON:0001893!3.91e-15!29;UBERON:0002780!4.92e-15!39;UBERON:0001890!4.92e-15!39;UBERON:0006240!4.92e-15!39;UBERON:0000956!8.19e-11!21;UBERON:0001869!8.19e-11!21;UBERON:0000203!8.19e-11!21;UBERON:0002619!1.60e-08!17;UBERON:0002410!8.22e-08!9;UBERON:0000010!2.57e-07!11
|ontology_enrichment_uberon=UBERON:0001017!4.65e-34!73;UBERON:0001016!5.27e-34!75;UBERON:0004121!2.22e-28!95;UBERON:0000924!2.22e-28!95;UBERON:0006601!2.22e-28!95;UBERON:0002346!4.10e-23!64;UBERON:0003075!4.10e-23!64;UBERON:0007284!4.10e-23!64;UBERON:0000073!3.85e-21!54;UBERON:0001049!4.77e-20!52;UBERON:0005068!4.77e-20!52;UBERON:0006241!4.77e-20!52;UBERON:0007135!4.77e-20!52;UBERON:0010371!1.00e-19!73;UBERON:0002020!3.33e-19!34;UBERON:0010314!2.53e-17!92;UBERON:0000955!2.01e-16!47;UBERON:0006238!2.01e-16!47;UBERON:0003056!3.91e-16!49;UBERON:0002616!9.14e-16!46;UBERON:0003080!2.36e-15!40;UBERON:0003528!3.91e-15!29;UBERON:0002791!3.91e-15!29;UBERON:0001893!3.91e-15!29;UBERON:0002780!4.92e-15!39;UBERON:0001890!4.92e-15!39;UBERON:0006240!4.92e-15!39;UBERON:0000956!8.19e-11!21;UBERON:0001869!8.19e-11!21;UBERON:0000203!8.19e-11!21;UBERON:0002619!1.60e-08!17;UBERON:0002410!8.22e-08!9;UBERON:0000010!2.57e-07!11
|tfbs_overrepresentation_for_novel_motifs=0.641384,0.801438,0.612053,0.688265,0.483253,0.704257,0.803568,0.370124,0.381467,0.162942,0.755749,0.790506,0.96877,0.81685,0.502646,0,1.02248,0.473993,0.352304,0.683591,1.39891,0.57409,0.815872,0.481455,1.50428,0.846564,0.342316,0.727368,0.535752,0.290745,0.711848,1.12823,2.06579,0.318879,2.17158,0.30022,0.460474,0.786577,0.434783,0.40068,3.09481,0.717547,1.64392,0.504971,1.10847,0.675898,0.938241,0.744678,0.162985,0.539131,1.0041,0.875451,0.771943,1.2746,1.29252,0.82458,0.549352,0.776619,0.331485,0.822375,1.10737,0.885556,0.39557,0.992216,0.8366,1.03484,1.43193,1.78579,1.1025,1.63712,1.44172,0.377213,0.205546,1.32691,0.323563,0.310084,0.318792,0.926147,1.08947,0.575233,0.986898,1.04072,0.884013,3.50716,1.20828,0.11855,0.129654,0.290918,0.943446,1.94914,1.50286,1.21342,1.14153,1.22838,0.430015,0.409166,0.367176,1.14445,0.938512,0.264911,0.460566,1.12793,1.25667,1.00472,1.00361,0.717061,1.06633,0.740267,0.580757,0.57247,0.633483,1.25851,0.576517,0.7614,1.51002,0.476467,0.143825,0.692434,1.02384,0.456123,1.33244,0.970073,0.848526,0.925183,1.56496,1.09333,1.90229,1.13449,1.43038,1.2358,1.23918,0.680176,4.96567,0.839311,1.53196,0.195549,2.65107,0.719099,1.482,2.31884,1.91709,7.1078,0.861473,1.1391,0.996781,0.718046,0.941555,2.27909,0.653418,0.485304,0.293812,0.184289,1.27621,0.416214,0.838313,1.35996,0.87653,0.516549,0.63863,0.650472,1.49167,1.20739,1.09379,1.52606,0.993294,0.830321,1.16191,0.788782,0.0824127
}}
}}

Revision as of 20:35, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:57504720..57504745,+p1@Fabp7
Mm9::chr10:57504766..57504779,+p3@Fabp7
Mm9::chr10:57504783..57504796,+p4@Fabp7
Mm9::chr10:57504816..57504829,+p@chr10:57504816..57504829
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
central nervous system4.65e-3473
nervous system5.27e-3475
ectoderm-derived structure2.22e-2895
ectoderm2.22e-2895
presumptive ectoderm2.22e-2895
neurectoderm4.10e-2364
neural plate4.10e-2364
presumptive neural plate4.10e-2364
regional part of nervous system3.85e-2154
neural tube4.77e-2052
neural rod4.77e-2052
future spinal cord4.77e-2052
neural keel4.77e-2052
ecto-epithelium1.00e-1973
gray matter3.33e-1934
structure with developmental contribution from neural crest2.53e-1792
brain2.01e-1647
future brain2.01e-1647
pre-chordal neural plate3.91e-1649
regional part of brain9.14e-1646
anterior neural tube2.36e-1540
brain grey matter3.91e-1529
regional part of telencephalon3.91e-1529
telencephalon3.91e-1529
regional part of forebrain4.92e-1539
forebrain4.92e-1539
future forebrain4.92e-1539
cerebral cortex8.19e-1121
cerebral hemisphere8.19e-1121
pallium8.19e-1121
regional part of cerebral cortex1.60e-0817
autonomic nervous system8.22e-089
peripheral nervous system2.57e-0711


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}